Clinical Trial Update: The Effect of Curcumin Against Colistin-induced Nephrotoxicity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating curcumin to mitigate colistin-induced nephrotoxicity in patients with acute kidney injury or drug-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Nephropathy
• Kidney Injury

Drugs mentioned

• Colistin (colistin)
• Curcumin (curcumin)

Snippet

Sponsor: October 6 University | Conditions: Acute Kidney Injury, Drug-Induced Nephropathy | Phase 3 | Status: UNKNOWN